Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

DaVita Inc V.DVA


Primary Symbol: DVA

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.


NYSE:DVA - Post by User

Post by gatmanon Nov 27, 2017 11:37am
196 Views
Post# 27038175

Basing

Basing
Technically, it's in the process of basing and under accumulation.  It's one of the few MJ related stocks that "has something" in the way of a real product and sales.
Although the future is unknown, I think I would just buy and hold here, awaiting positive developments.
With regard to my previous comments on a raise, the present market environment is favorable for many raises and when announced, their respective stocks do not drop but go up.  Presumably, the market sees the increased strenthening of the financial position (more cash in the treasury) as a positive now, not a negative.  Interesting times.
<< Previous
Bullboard Posts
Next >>